Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Abatacept for Graft Versus Host Disease Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease: a Sickle Transplant Alliance for Research Trial

Next Previous
Trial Profile

Abatacept for Graft Versus Host Disease Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease: a Sickle Transplant Alliance for Research Trial

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 17 Jun 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Abatacept (Primary) ; Alemtuzumab; Antithymocyte globulin; Ciclosporin; Diphenhydramine; Diphenhydramine; Fludarabine; Melphalan; Methotrexate; Methylprednisolone; Mycophenolate mofetil; Paracetamol; Pethidine; Sirolimus; Tacrolimus; Thiotepa
  • Indications Graft-versus-host disease
  • Focus Adverse reactions

Most Recent Events

  • 11 Jun 2024 Status changed from active, no longer recruiting to completed.
  • 04 Aug 2021 Planned End Date changed from 30 Jun 2021 to 30 Dec 2021.
  • 04 Aug 2021 Planned primary completion date changed from 30 Jun 2021 to 30 Dec 2021.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top